Light and electron microscopic immunohistochemical detection of bromodeoxyuridine-labeled cells in the brain:

Laura B Ngwenya1, Alan Peters, Douglas L Rosene

  • 1Department of Anatomy & Neurobiology, Boston University School of Medicine, 715 Albany St., Boston, MA 02118, USA. ngwenya@bu.edu

Insights

Bromodeoxyuridine (BrdU) immunohistochemistry effectively labels new brain cells across various fixation methods. This study confirms reliable BrdU cell detection in paraformaldehyde, glutaraldehyde-paraformaldehyde, and unfixed frozen brain tissues.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Histology

Background:

  • Bromodeoxyuridine (BrdU) immunohistochemistry is crucial for identifying newly generated cells in the brain.
  • Standard protocols often use paraformaldehyde fixation, but alternative methods are needed for electron microscopy and biochemical studies.
  • Previous research lacked systematic comparisons of different fixatives for BrdU labeling in brain tissue.

Purpose of the Study:

  • To systematically compare the efficacy of Bromodeoxyuridine (BrdU) immunohistochemistry across different tissue fixation methods.
  • To evaluate BrdU labeling in brain tissue fixed with paraformaldehyde, glutaraldehyde-paraformaldehyde, and unfixed frozen samples.
  • To develop and assess an electron microscopy protocol for visualizing BrdU-labeled cells.

Main Methods:

  • Brain tissues from rats and monkeys were fixed using 4% paraformaldehyde, a mixed glutaraldehyde-paraformaldehyde solution, or were unfixed and flash-frozen.
  • Immunohistochemistry protocols were optimized for each fixation type.
  • Light microscopy with diaminobenzidine and confocal microscopy with double-label immunofluorescence were used for qualitative assessment.
  • Quantitative stereological analysis was performed on BrdU-labeled cells in the rat dentate gyrus.
  • A protocol for electron microscopy visualization of BrdU-labeled cells was developed.

Main Results:

  • Excellent Bromodeoxyuridine (BrdU) labeling was observed in brain tissue regardless of fixation method (paraformaldehyde, glutaraldehyde-paraformaldehyde, unfixed).
  • Quantitative stereological assessment revealed no significant differences in the number of BrdU-labeled cells detected across the different fixation protocols.
  • The developed electron microscopy protocol successfully visualized BrdU-labeled cells in both rat and monkey brains, preserving fine ultrastructural detail.

Conclusions:

  • Bromodeoxyuridine (BrdU) immunohistochemistry is robust and effective for labeling newly generated cells in the brain, irrespective of whether tissues are fixed with paraformaldehyde, glutaraldehyde-paraformaldehyde, or are unfixed.
  • The choice of fixation method does not significantly impact the quantitative detection of BrdU-labeled cells.
  • A reliable electron microscopy protocol is now available for visualizing BrdU-labeled cells, enabling correlative light and electron microscopy studies.

Related Concept Videos